Sutro Biopharma, Inc.

US$9.62As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:STROHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (28.74%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.55
PE TTM —
TSR TTM (14.11%)
Mkt cap US$159.5M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$11
13.00%
(3.68%)
Hold 1|8|1|6|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.17
0.18
0.17
0.19
25.54%
24.01%
20.31%
20.93%
Revenue$M
14.43
14.75
14.95
14.76
13.96%
15.18%
14.32%
7.04%
Peers (US$159.5M)
Cap (US$)
PE
159.2M
—
Capital
TTM
5Y
10Y
Leveragex
1.100
0.342
0.298
EBIT/Intx
2.248
0.539
0.526
Own earn%
149.04
(15.40)
(15.04)
Sh yield%
23.63
48.80
46.42
Owners
Insiders/Inst%
1.53
68.83
Short interest%
1.46
SBC / revenue%
1.78
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
22–27
$1 testx
—
Incr. ROIC%
14